A 48-year-old recreational runner presented with severe right-sided sciatica from an L5-S1 disc herniation after a surgeon recommended fusion. Through a structured non-surgical spine treatment program combining targeted physical therapy, mechanical decompression, and a single platelet-rich plasma injection, she avoided surgery, resolved her radicular pain, and returned to running 25 weekly miles within nine months.

This case study is part of our broader resource on non-surgical spine treatment and demonstrates how conservative care, sequenced correctly, often resolves the same conditions surgeons label as fusion candidates. It complements our pillar coverage of spinal fusion alternatives by showing what an actual treatment timeline looks like for a motivated patient with a single-level disc lesion.

The patient asked for her story to be shared on the condition that all identifying details were removed. Names, dates, and unique demographic specifics have been anonymized. Clinical metrics, imaging findings, and treatment milestones are reported as documented in her chart.

Context and Baseline

The patient was an experienced recreational runner who had averaged 30 to 40 miles per week for over a decade. Eight months before her first ValorSpine visit, she developed acute right-sided low back pain after a long trail run, followed within 72 hours by sharp pain radiating down the back of her right leg into the foot. Sitting and forward bending reproduced the leg pain. Walking briefly relieved it.

An MRI obtained four weeks after symptom onset showed a 6 mm right paracentral disc herniation at L5-S1 with effacement of the traversing S1 nerve root. Her primary care physician referred her to an orthopedic spine surgeon, who recommended a single-level L5-S1 fusion after two epidural steroid injections failed to provide durable relief. She declined and sought a second opinion focused on conservative options.

At her ValorSpine intake, baseline measures were:

• Visual Analog Scale (VAS): right leg 78 mm, low back 54 mm
• Oswestry Disability Index (ODI): 42 (severe disability range)
• Straight leg raise positive at 35 degrees on the right
• S1 distribution numbness in the lateral foot
• No motor weakness, no bowel or bladder symptoms, no red flags
• Running: zero miles per week for the prior six months

Her presentation was consistent with the broad clinical literature showing that 80 to 90 percent of sciatica cases resolve without surgery when patients receive structured conservative care. Importantly, she had no progressive neurological deficit, no cauda equina signs, and good motivation — the three factors most predictive of a successful non-surgical course.

Approach

The treating clinician designed a sequenced, multi-modality program rather than a single-tool intervention. The reasoning: each modality addresses a different mechanism. Physical therapy retrains motor control and tissue tolerance. Mechanical decompression unloads the nerve root. Targeted biologic injection (PRP) addresses the inflammatory and reparative biology of the disc and adjacent tissue. Stacked in the right order, the modalities reinforce each other.

The program drew on the same principles described in our review of spinal fusion alternatives and shares structural elements with the protocols documented in the cervical radiculopathy fibrin case study and the post-whiplash cervical fibrin case study, adapted for a lumbar disc herniation with radiculopathy.

The treatment plan was framed as three sequenced phases:

1. Phase 1 (Weeks 1-6) — Calm the nerve. Reduce radicular pain enough to enable active rehabilitation. Mechanical decompression plus directional preference exercises.
2. Phase 2 (Weeks 6-14) — Rebuild capacity. Progressive loading, hip and core strengthening, gait normalization. Single PRP injection at week 8 to support disc and peri-radicular tissue repair.
3. Phase 3 (Weeks 14-36) — Return to running. Graded run-walk progression, volume rebuild, periodic check-ins.

Implementation

Phase 1: Mechanical Decompression and Directional Therapy

The patient completed 18 sessions of lumbar mechanical decompression over six weeks, with her clinician selecting traction parameters appropriate for an L5-S1 herniation. Published cohort data on spinal decompression report roughly 36.8 percent sustained improvement at six months when used as a standalone intervention. Combined with active rehabilitation, response rates in the literature are higher.

Concurrently, she performed a directional preference program twice daily — prone press-ups and standing extensions — which centralized her leg pain into the low back within the first ten days. Centralization is a strong positive prognostic sign in disc-related radiculopathy and was the inflection point that justified continuing the conservative path.

By the end of Phase 1, her right leg VAS had dropped from 78 to 41. Low back VAS held roughly steady at 49. Straight leg raise improved from 35 to 60 degrees.

Phase 2: Strength, Capacity, and a Single PRP Injection

Phase 2 introduced progressive loading: hip-hinge patterns, glute and posterior chain strengthening, and graded core endurance work. The clinician avoided early flexion-loaded movements and introduced them only after pain stabilized below 30 mm.

At week 8, the patient received a single platelet-rich plasma injection delivered to the peri-annular region of the L5-S1 disc under fluoroscopic guidance. PRP cohort data show that approximately 47 percent of patients achieve at least 50 percent pain relief at six months. The injection was selected over an additional epidural steroid because the prior steroid injections had not produced durable relief and the goal had shifted from temporary symptom suppression to tissue-level support of the natural healing trajectory she was already on.

By week 14, her right leg VAS was 19 mm, low back VAS was 22 mm, ODI had dropped to 18, and she was tolerating 45 minutes of brisk walking without symptom flare.

Phase 3: Return to Running

Phase 3 used a structured run-walk progression starting at one minute of running interspersed with two minutes of walking, repeated for 20 minutes total, three days per week. Volume increased weekly only if the next-day low back VAS stayed below 25 mm.

By week 24 she was running 30 minutes continuously. By week 36 she had rebuilt to 25 weekly miles across four runs, including one weekend long run of 8 miles.

Results

Outcome metrics at the nine-month follow-up are summarized below.

Surgery was avoided. The patient returned to her sport at her prior weekly mileage. She remained off prescription pain medications throughout treatment after week 4 and reported no functional limitations at her nine-month visit.

Her trajectory is consistent with the broader picture for sciatica patients: 80 to 90 percent resolve without surgery when conservative care is structured around progressive load tolerance rather than pain avoidance. Her trajectory also fits the pattern seen in patients who decline recommended spine surgery — nearly 1 in 5 patients told they need spine surgery choose not to have it, and many of them do well with appropriate non-surgical care.

Lessons Learned

Three observations from this case generalize to other patients with disc-related radiculopathy.

Sequencing matters more than tool selection. Mechanical decompression delivered in week 1 produced different results than the same modality would have produced in week 14. The same is true of PRP — placed at week 8, after centralization had occurred and motor control had been restored, it supported a process already in motion. Placed at week 1, it would have addressed an angry, untrained system.

Centralization is the early signal worth chasing. When pain moves from the leg toward the spine in response to a directional preference exercise, the patient is on a non-surgical trajectory. When pain peripheralizes despite appropriate exercise, the prognosis for non-surgical resolution is weaker and the case requires re-evaluation.

Active rehabilitation, not passive modality stacking, drove the outcome. The decompression sessions and the PRP injection were adjuncts. The patient’s daily directional exercises, progressive strengthening, and graded return-to-running plan did the bulk of the work. Patients looking for non-surgical relief without the daily commitment to active rehabilitation rarely match these outcomes.

Expert Take

This case is not unique. It is representative of what happens when a single-level disc herniation with radiculopathy is treated with a sequenced conservative program rather than a single intervention. Fusion remains an appropriate option for progressive neurological deficit, cauda equina, intractable pain that defies conservative management, or structural instability. For everyone else — which is most patients — the question is not surgery versus no surgery. It is whether the non-surgical program is structured well enough to give the natural healing trajectory a fair chance.

Patients pursuing similar conservative paths often find value in reviewing outcomes from related cases, including our failed back surgery fibrin case study, the veteran annular tear fibrin case study, and the adjacent segment disease fibrin case study.

Transparency: What We Would Do Differently

Two elements of this case are worth examining critically.

First, the two pre-referral epidural steroid injections produced minimal durable benefit, consistent with the AAFP systematic review finding that epidural steroid injections are not effective for chronic low back pain alone. In hindsight, those injections delayed the start of structured conservative care by roughly six weeks. Earlier referral to a structured non-surgical program would have shortened the total recovery timeline.

Second, while a single PRP injection was clinically appropriate here, the decision to use PRP rather than an intra-annular fibrin injection was driven by the absence of a discrete annular tear on imaging. Had the imaging shown a clean annular fissure, fibrin disc treatment would have been a stronger first-line biologic choice.

Finally, the patient’s compliance was unusually high. A patient with the same imaging findings but lower exercise tolerance, a more sedentary baseline, or significant psychosocial barriers would not necessarily achieve the same trajectory on the same protocol. Outcomes generalize only as far as the underlying behavioral inputs do.

Frequently Asked Questions

Can sciatica from a disc herniation really resolve without surgery?

Yes. The clinical literature consistently shows that 80 to 90 percent of sciatica cases resolve without surgery when patients receive structured conservative care. The exceptions are progressive neurological deficit, cauda equina syndrome, and intractable pain that fails an adequate non-surgical trial.

How long does non-surgical recovery from a lumbar disc herniation take?

Most patients with a single-level disc herniation and radiculopathy see meaningful improvement in 6 to 12 weeks of structured care, with full return to demanding activities such as running typically taking 6 to 9 months. The timeline depends on baseline fitness, severity of the herniation, and adherence to the rehabilitation program.

Why was a fusion recommended if conservative care worked?

Fusion is a reasonable option for some patients with refractory radiculopathy, but it is not the only one. Roughly 40 percent of back surgeries do not achieve the patient’s desired outcome. A second opinion focused on non-surgical options is appropriate whenever surgery is recommended for a single-level disc herniation without red-flag features.

Was the PRP injection necessary in this case?

The patient’s improvement was already in motion before the PRP injection. PRP cohort data show that about 47 percent of patients achieve at least 50 percent pain relief at six months. In this case, the injection was used as an adjunct to support tissue-level recovery, not as a standalone treatment.

Who is not a good candidate for a non-surgical program like this?

Patients with progressive motor weakness, cauda equina symptoms, severe instability, or large extruded fragments compressing the cord are surgical candidates. Patients without those features but with poor exercise tolerance, untreated psychosocial drivers of pain, or unwillingness to engage with active rehabilitation see weaker results from any conservative program.

How is this different from intra-annular fibrin injection?

Intra-annular fibrin injection — a form of biologic disc repair — is targeted at sealing annular tears and supporting disc healing. PRP delivered peri-annularly addresses inflammation and surrounding tissue biology. The two are complementary, not interchangeable. Imaging and clinical presentation determine which is appropriate.

Sources and Further Reading

• American Academy of Family Physicians — systematic review of epidural steroid injections for chronic low back pain
• National Institute of Neurological Disorders and Stroke — clinical overview of sciatica and lumbar radiculopathy
• Journal of Neurosurgery — outcomes data for lumbar fusion and revision rates
• Peer-reviewed cohort studies on platelet-rich plasma for disc-related pain — outcomes at 6 months
• Published cohort data on lumbar mechanical decompression — sustained improvement at 6 months
• Peer-reviewed clinical literature on intra-annular fibrin injection — VAS and satisfaction outcomes at 2-year follow-up

Ready to Explore Non-Surgical Options?

Ready to explore non-surgical options for your back pain? Schedule your consultation with ValorSpine today.